|
⚲
|
| Keyboard |
| Bali Muralidhar | |
|---|---|
| Firm | |
| Address | c/o Spruce Biosciences, Inc 611 Gateway Boulevard, Suite 740 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| AdvanCell Inc | 021-591090 | Director | 218.3 M of 315.0 M |
||
| Spruce Biosciences Inc | 021-561207 | Director | 50.0 M of 50.0 M |
||
| Wugen Inc | 021-556954 | Director | 109.5 M of 163.0 M |
||
| Spruce Biosciences Inc | 021-474453 | Director | 53.6 M of 53.6 M |
||
| Wugen Inc | 021-407570 | Director | 37.2 M of 37.2 M |
||
| Wugen Inc | 021-407610 | Director | 98.5 M of 172.0 M |
||
| Reneo Pharmaceuticals Inc | 021-383843 | Director | 47.4 M of 94.8 M |
||
| Spruce Biosciences Inc | 021-361655 | Director | 88.0 M of 88.0 M |
||